Alliancebernstein L.P. Moderna, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 329,734 shares of MRNA stock, worth $13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

329,734

Previous 405,705 18.73%

Holding current value

$13 Million

Previous $48.2 Million 54.26%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $4.83 Million - $9.51 Million	-75,971 Reduced 18.73%	329,734 $22 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $2.06 Million - $3.39 Million	20,343 Added 5.28%	405,705 $48.2 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $2.67 Million - $3.61 Million	-31,264 Reduced 7.5%	385,362 $41.1 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $1.99 Million - $2.99 Million	-28,598 Reduced 6.42%	416,626 $41.4 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $4.62 Million - $6.07 Million	47,962 Added 12.07%	445,224 $46 Million
Q2 2023 Aug 15, 2023	SELL	$118.5 - $160.53 $187,230 - $253,637	-1,580 Reduced 0.4%	397,262 $48.3 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $12.5 Million - $18.1 Million	-91,916 Reduced 18.73%	398,842 $61.3 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $1.66 Million - $2.94 Million	-13,984 Reduced 2.77%	490,758 $88.1 Million
Q3 2022 Nov 15, 2022	SELL	$118.07 - $194.18 $667,921 - $1.1 Million	-5,657 Reduced 1.11%	504,742 $59.7 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $4.52 Million - $6.82 Million	38,595 Added 8.18%	510,399 $72.9 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $4.44 Million - $8.25 Million	-35,100 Reduced 6.92%	471,804 $81.3 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $5.85 Million - $9.54 Million	-25,884 Reduced 4.86%	506,904 $129 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $77.7 Million - $170 Million	350,317 Added 191.99%	532,788 $205 Million
Q2 2021 Jul 30, 2021	BUY	$129.91 - $234.98 $2.05 Million - $3.7 Million	15,755 Added 9.45%	182,471 $42.9 Million
Q1 2021 May 06, 2021	BUY	$109.18 - $185.98 $705,630 - $1.2 Million	6,463 Added 4.03%	166,716 $21.8 Million
Q4 2020 Feb 08, 2021	SELL	$65.74 - $169.86 $2,563 - $6,624	-39 Reduced 0.02%	160,253 $16.7 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $612,411 - $1.07 Million	11,270 Added 7.56%	160,292 $11.3 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $910,898 - $2.46 Million	30,701 Added 25.95%	149,022 $9.57 Million
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $370,890 - $658,758	20,860 Added 21.4%	118,321 $3.54 Million
Q4 2019 Feb 18, 2020	BUY	$13.93 - $21.28 $515,967 - $788,211	37,040 Added 61.3%	97,461 $1.91 Million
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $81,700 - $120,418	6,664 Added 12.4%	60,421 $962,000
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $479,911 - $992,750	35,030 Added 187.06%	53,757 $787,000
Q1 2019 May 14, 2019	BUY	$14.45 - $23.7 $270,605 - $443,829	18,727 New	18,727 $381,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Moderna, Inc. Transaction History